BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.

    BIOTECH & PHARMA

    Biotech and pharma stocks listed on the ASX.
    Paradigm Biopharmaceuticals ASX PAR osteoarthritis pain reduction knee Pentosan Polysulfate Sodium

    Paradigm Biopharma raises the stakes in osteoarthritis pain reduction

    AVITA Medical ASX AVH FDA compassionate use expanded access RECELL device

    AVITA Medical receives FDA boost for compassionate use of RECELL device

    Harvey Nichols UK MGC Pharmaceuticals ASX MXC CBD Derma range cannabidiol

    UK’s Harvey Nichols to expand MGC Pharmaceuticals CBD Derma range

    CannPal Animal Therapeutics ASX CP1 veterinary research University of Melbourne

    CannPal Animal Therapeutics to conduct veterinary research alongside the University of Melbourne

    Immutep ASX IMM biotech recruits final patient melanoma trial Canada patent antibody

    Immutep recruits final patient for melanoma trial, receives Canadian patent for antibody

    Paradigm Biopharmaceuticals ASX PAR phase 2b clinical trial knee osteoarthritis recruitment

    Fast knee pain trial recruitment boosts Paradigm Biopharmaceuticals

    Acrux ASX ACR FDA generic onychomycosis drug Jublia US Food and Drug Administration

    FDA accepts Acrux application for generic version of nail fungus drug Jublia

    Genetic Signatures ASX GSS EasyScreen respiratory technology pathogen detection kit

    Genetic Signatures secures ‘major’ sales contract for EasyScreen respiratory technology

    Creso Pharma ASX CPH Middle East Israel medical cannabis

    Creso Pharma looks to the Middle East for medical cannabis commerce

    ResApp Health ASX RAP ResAppDx technology SMARTCOUGH-C-2 study acute respiratory disease children

    ResApp Health completes enrolment for acute respiratory disease study

    Cynata Therapeutics ASX CYP stem cells regenerative medicine positive efficacy data study Cymerus mesenchymal MSCs heart attack

    Cynata study shows positive link between stem cells and cardiac function post-heart attack

    Phylogica ASX PYC peptide vaccine T-Cell expansion results in vivo

    Phylogica reports positive peptide vaccine T-Cell expansion results in vivo

    Load more
    Small Caps ASX Australian stock market
    Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

    Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held.
    See a financial expert before making any investment decision.
    Copyright 2018 Small Caps. All rights reserved.